Brief Description
Evercrisp Biosciences is a biotechnology company engineering self-deliverable CRISPR genome editors intended to improve the area of oncology. The company focuses on the discovery and development of protein-based genome editors as therapeutics for multiple disease areas, enabling healthcare organizations to have novel enzymes with high cell permeability and editing efficiency.
Inventors
Jennifer Doudna
Company Founders
UC Berkeley Professor Jennifer Doudna (Molecular and Cell Biology and Chemistry), Tanja Kortemme, Spiros Liras
Timeline
- 2021. Company founded.